Condition 1: Anxiety. Condition 2: Depression. Anxiety disorder, unspecified Major depressive disorder, single episode, unspecified
Conditions
Interventions
Intervention 1: The first intervention group: patients with a serum level of 25-hydroxyvitamin D3 less than 12 ng/ml receive 8 pearls of 50000 units of cholecalciferol from Zahravi Pharmaceutical Comp
Sponsors
Islamic Azad University
Zahravi Pharmaceutical Company
Reza Radiotherapy and Oncology Center
Omid parsina damavand pharmaceuitical company
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Ability to read and write in Persian Ability to answer questionnaire questions
Exclusion criteria
Exclusion criteria: Complicated diabetes or hypertension History of visiting a psychiatrist or psychologist in the last 6 months or taking psychotropic drugs in the last 6 months Pregnancy Breastfeeding Taking vitamin D or vitamin D3 analogs in the last 3 months Vitamin D serum level more than 100 ng/ml
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression score in Zung questionnaire. Timepoint: Before starting intervention, 90 days after starting to take cholecalciferol. Method of measurement: Zung Self-Rating Depression Scale questionnaire.;Anxiety score in Zung questionnaire. Timepoint: Before starting intervention, 90 days after starting to take cholecalciferol. Method of measurement: Zung Self-Rating Depression Scale qestionnaire.;Serum level of 25-hydroxy vitamin D3. Timepoint: Before starting the intervention and 90 days after starting cholecalciferol. Method of measurement: enzyme-linked immunosorbent assay. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReyhaneh Entezari heravi
Islamic Azad University
Outcome results
None listed